Envista Holdings Corporation will release its fourth quarter 2025 results on Thursday, February 5, 2026, and host a conference call beginning at 2:00 PM Pacific Time, lasting approximately one hour. Investors can access the live webcast and accompanying slide presentation through the Investors section of Envista’s website, with a replay available shortly after the call and remaining online for one year. U.S. participants may dial 1-800-836-8184, while international callers should use 1-646-357-8785, referencing Conference ID 54406. Envista will publish its earnings press release, slide deck and related materials on its website in advance of the call and maintain these resources for subsequent review, offering analysts and portfolio managers ample time to assess quarterly performance trends, margin drivers and free cash flow expectations ahead of full-year guidance.

On Monday, January 12, 2026, from 3:45 to 4:25 PM Pacific Time, Envista’s executive leadership will deliver a formal presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. The live audio webcast will be accessible via the Investors section of Envista’s website, with a replay hosted for 30 days following the event. Management is expected to discuss progress across its core dental technology franchises—DEXIS, Kerr, Nobel Biocare and Ormco—including market share shifts in implantology and digital orthodontics, recent product approvals and the impact of its Envista Business System on operational efficiency. The session offers investors direct insight into Envista’s strategic priorities for 2026 and its outlook on capital allocation, R&D investment and potential M&A opportunities within the $43 billion global dental equipment and consumables market.